Drug Name:
CARNITOR Rx
Generic Name and Formulations:
Levocarnitine 330mg; tabs.
Company:
Leadiant Biosciences, Inc.
Therapeutic Use:
Indications for CARNITOR:
Primary systemic or secondary carnitine deficiency.
Adult:
990mg 2–3 times daily.
Children:
Give in divided doses. Initially 50mg/kg/day; range 50–100mg/kg (max 3g) per day.
Warnings/Precautions:
Obtain baseline carnitine level; monitor blood chemistry, carnitine levels, vital signs, clinical condition. Seizure disorders. Renal insufficiency (oral forms). Pregnancy. Nursing mothers: not recommended.
See Also:
Interactions:
Monitor INR with warfarin.
Adverse Reactions:
GI upset/pain, body odor, seizures; hypersensitivity reactions (discontinue if occur). Inj: also inj site reactions.
How Supplied:
Tabs—90; Oral soln—118mL; Single-dose vials (5mL)—5
Neurology Advisor Articles
- Ajovy Injection Approved for Migraine Prevention in Adults
- Few With Acute Migraine Take Triptans, Many Discontinue the Drug
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Noninvasive Ventilation Effective in Amyotrophic Lateral Sclerosis Treatment
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Drug Prices Increase More Than Expected After Shortages
- Potentially Inappropriate Opioid Prescribing Tied to Overdose
- Loss of Function Variants in LRKK1 and LRKK2 Not Linked to Parkinson Disease
Sign Up for Free e-newsletters
Check out what's trending
CME Focus
Tardive Dyskinesia Clinical Commentary
CME
1.00 Credits
Breaking the Vaccination Barrier in Adults
CME|CE
1.25 Credits